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Abstract Wnt/b-catenin pathway, the effectors of which
are transcription factors of the LEF1/TCF family, is pri-
marily associated with development. Strikingly, however,
some of the genes of the pathway are schizophrenia sus-
ceptibility genes, and the proteins that are often mutated in
neurodegenerative diseases have the ability to regulate
b-catenin levels. If impairment of this pathway indeed
leads to these pathologies, then it likely plays a physio-
logical role in the adult brain. This review provides an
overview of the current knowledge on this subject. The
involvement of b-catenin and LEF1/TCF factors in adult
neurogenesis, synaptic plasticity, and the function of tha-
lamic neurons are discussed. The data are still very pre-
liminary and often based on circumstantial or indirect
evidence. Further research might help to understand the
etiology of the aforementioned pathologies.
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Introduction
b-Catenin, its Functions and Regulation
b-Catenin has diverse functions in a cell that are mediated
by its interactions with other proteins. b-Catenin stabilizes
cell–cell junctions by anchoring cell adhesion molecules
(i.e., Cadherins) in the actin cytoskeleton, activates the
LEF1/TCF family of transcription factors, and is involved
in the amplification and separation of centrosomes [1].
b-Catenin is abundant at the plasma membrane, but its
cytoplasmic/nuclear pool is tightly regulated.
The majority of b-catenin is bound to trans-membrane
Cadherin proteins. This complex, connected to actin via
a-catenin, constitutes adherens junctions by which cells
attach firmly to one another [1] (Fig. 1a). In neurons,
membranous b-catenin plays an additional role in the
synapse. Catherin-b-catenin adhesion complexes form
symmetric synaptic junctions that border synaptic active
zones [2]. Synaptic b-catenin regulates the size and local-
ization of vesicle clusters by interacting with PDZ proteins
at presynaptic sites [3–5]. It also targets some scaffolding
molecules at postsynaptic sites [6, 7] and influences
excitatory postsynaptic strength [8]. Detailed reviews on
the role of b-catenin and Cadherins in synapses can be
found elsewhere [9–11].
The cytoplasmic fraction of b-catenin is regulated by
phosphorylation in a destruction complex that is composed
of glycogen synthase kinase 3a (GSK3a) or GSK3b and
two scaffolding proteins, AXIN and adematous polyposis
coli (APC) [12]. The phosphorylation of b-catenin by
GSK3a/b creates a signal for its rapid degradation in the
proteasome. A classic way that b-catenin is activated is the
inhibition of GSK3a/b in the canonical Wnt signaling
pathway, which is also called the Wnt/b-catenin pathway
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(Fig. 1b). Signal transduction is initiated by the interaction
between secreted glycoproteins, Wnts (mammals have 19
Wnt proteins), and Frizzled receptors (mammals have 10),
in a paracrine or autocrine fashion. Upon the binding of
Wnt to Frizzled receptors and low-density lipoprotein
receptor-related protein 5 or 6 (LRP5/6) co-receptors, the
destruction complex is inhibited, promoting the accumu-
lation of b-catenin and enabling its translocation to the
nucleus. Thereafter, together with LEF1/TCF transcription
factors, b-catenin acts as a transcriptional activator. Four
LEF1/TCF transcription factors have been identified:
LEF1, TCF7, TCF7L1, and TCF7L2 (the last three are also
known as TCF1, TCF3, and TCF4, respectively). These
factors belong to the high mobility group family and bind
the same DNA motif; however, they can mediate diverse
functions by activating different sets of genes [13]. The
canonical Wnt pathway is one of the principal develop-
mental pathways. It is involved in body axis specification,
morphogenesis, and stem cell proliferation and differenti-
ation [14]. Its role in forebrain development, including
neurogenesis, is very well established [15–18]. New data
suggest that it can also be active in adult neurogenic
niches and in postmitotic neurons, which will be discussed
below.
The inhibition of GSK3a/b by Wnt signaling, b-catenin
stabilization and LEF1/TCF transcription factor activation
are closely linked events, but they are not inseparable.
Canonical signaling (Fig. 2a) can diverge from the classic
pathway downstream of GSK3a/b (Fig. 2b). For example,
in neurons, the inhibition of GSK3a/b by Wnt can lead to a
decrease in microtubule-associated protein 1B (MAP1B)
phosphorylation by this kinase, resulting in microtubule
stabilization [19, 20]. b-Catenin can also be stabilized by
Wnt-independent mechanisms. The present review refers to
any mechanism of b-catenin stabilization and activation of
LEF1/TCF transcription factors as b-catenin/TCF signaling.
Several excellent recent reviews have been published on
the role of synaptic b-catenin and ‘‘divergent canonical’’
(i.e., Wnt/GSK3) (Fig. 1b) and noncanonical Wnt (diverse
Wnt/Frizzled-initiated signaling independent of GSK3a/b
inhibition) pathways (Fig. 2c–f) in synaptic plasticity [10,
21]. This review does not discuss these topics but rather
focuses on the involvement of b-catenin/TCF signaling in
neuronal function, which is a relatively new and enigmatic
topic.
b-Catenin/TCF Signaling and Adult Brain Pathologies
GSK3a/b has been implicated in affective and psychotic
disorders and neurodegeneration. Unclear, however, is
whether GSK3a/b acts through b-catenin in these brain
pathologies. Nevertheless, some links have been made
between b-catenin/TCF signaling and schizophrenia,
bipolar disorder, Alzheimer’s disease, Parkinson’s disease,
and Huntington’s disease (AD, PD, and HD, respectively).
For the latter diseases, some proteins that are encoded
by genes that are mutated in neurodegenerative disorders


































Fig. 1 b-Catenin plays two main functions in the cell. a b-Catenin
interacts with Cadherins at the internal site of the membrane and links
them to the actin cytoskeleton together with a-catenin. b Cytoplasmic
b-catenin plays an effector role in the canonical Wnt pathway. In the
absence of WNT ligands, b-catenin is phosphorylated by GSK3a/b
and subsequently degraded in the proteasome. Upon Wnt stimulation
of a Frizzled receptor, Dishevelled (DVL) recruits AXIN to the LRP5/6
co-receptor, b-catenin is stabilized, enters the nucleus, and activates
LEF1/TCF transcription factors
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AD) have been shown to regulate b-catenin levels [22–25].
In the case of psychotic and mood disorders, scientists’
attention turned to the potential involvement of b-catenin
with the discovery that lithium ions, a classic and effective
medication for bipolar disorder, can inhibit GSK3a/b [26,
27]. Interestingly, the FZD3, GSK-3b, DKK4, APC, and
TCF7L2 genes that encode Wnt pathway components have
been shown to be associated with susceptibility to schizo-
phrenia [28–33]. Moreover, anxiety-like phenotypes were
observed in Tcf7l2 haplo-insufficient mice [34], whereas
the brain-specific overexpression of b-catenin exerted mood-
stabilizing-like effects in standard models of mania and
depression [35], suggesting a connection between dysregu-
lated b-catenin/TCF signaling and psychiatric disorders.
Until now, the involvement of b-catenin in brain
pathologies is only an attractive hypothesis. Before it can
be either confirmed or rejected, more research should be
conducted to determine the physiological role of the
b-catenin/TCF signaling pathway in neurons in the adult
brain. The present review summarizes the current knowl-
edge on this subject.
b-Catenin Signaling in Adult Neurogenesis
Canonical Wnt/b-catenin signaling plays a crucial role in
development in general. Specifically, it is involved in
multiple aspects of central nervous system development
[15, 17, 18, 36, 37]. b-Catenin has been shown to regulate
the self-renewal of neural progenitor cells and neuronal
differentiation in the developing neocortical ventricular
zone [15, 16, 38, 39], subcortical areas of the telencephalon
[40], and ventral midbrain [41]. This raises the issue of
whether canonical Wnt signaling is also involved in adult
neurogenesis.
Adult Neurogenic Niches
In the adult brain, neurogenesis persists in the subventric-
ular zone (SVZ) of the lateral ventricle in the cortex and
subgranular zone (SGZ) in the hippocampus [42]. Two
types of adult neural stem cells or neural progenitor cells
(aNPCs) have been characterized in these germinal zones:
primary progenitors that are slowly dividing cells and
intermediate progenitors that intensively proliferate. Both
types of aNPCs express the SOX2 marker. The primary
progenitors, glial fibrillary acidic protein (GFAP)-positive
cells, have a radial glia-like phenotype and are named Type
1 progenitors in the SVZ and B progenitors in the SGZ.
They have the capacity to generate neurons, astrocytes, and
oligodendrocytes. The intermediate progenitors that
express proneuronal factor MASH1? are called Type 2 or
C progenitors, respectively. During neurogenesis, the































Canonial Wnt „Divergent” canonial Wnt PCP, non-canonical Wnt Ca2+, non-canonical Wnt
Fig. 2 Wnt ligands induce diverse Wnt pathways. a, b Wnt ligands bind
Frizzled receptors and activate canonical Wnt signaling. The inhibition
of GSK3a/b in the canonical Wnt pathway can lead to the activation of
b-catenin or influence other targets of GSK3a/b. These two possibilities
can be called the Wnt/b-catenin pathway and ‘‘divergent canonical’’
Wnt pathway, respectively. c Other WNT molecules and Frizzled
receptors can activate planar cell polarity (PCP) signaling, in which
downstream messenger are ROCK and JNK kinases. d WNT5a can
regulate intracellular level of Ca2?, which is involved in many cellular
signalings and can inhibit b-catenin/TCF signaling. e, f WNT molecules
can also bind to the receptor tyrosine kinases (RTK) ROR and RYK. The
Wnt/RYK pathway regulates neuronal differentiation
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among others by TUJ1 expression, and give rise to pro-
liferating and migrating neuroblasts that are doublecortin
(DCX) and polysialic acid-neural cell adhesion molecule
(PSA–NCAM)-positive. DCX and PSA–NCAM are also
markers of new neurons that additionally express the pan-
neuronal marker NeuN.
The major adult neurogenic niche is the SVZ, from
which neuroblasts migrate along the rostral migratory
stream (RMS) to the olfactory bulbs and differentiate into
dopaminergic and c-aminobutyric acid (GABA) interneu-
rons. The neuroblasts from the SGZ migrate only a short
distance and give rise to granular glutamatergic neurons
that integrate in the dentate gyrus of the hippocampus. The
progression from aNPCs to differentiated neurons involves
progenitor cell maintenance and proliferation, a cell-fate
decision, neuroblast proliferation and migration, neuronal
maturation, and finally the integration of new neurons into
the neuronal circuitry. All of the stages of neurogenesis
occur through the implementation of internal genetic and
epigenetic programs and are under the control of micro-
environmental factors [43–45]. One of the implicated sig-
naling pathways is Wnt/b-catenin.
Activity of the Canonical Wnt Pathway in the Adult
Neurogenic Niche
Several components of the canonical Wnt pathway have
been described in the adult neurogenic niche. The Wnt3,
Wnt5a, Wnt7a, Wnt8b, and Frizzled receptor (Fz) 1, 2, and
9 genes are expressed in the SGZ of the dentate gyrus and
hilus [46, 47], whereas Wnt1, Wnt5a, Wnt7a, Wnt7b, Fz3,
Fz4, Fz7, Fz8, and Fz9 are expressed in cortical aNPCs in
the SVZ or along the RMS [46, 48]. This suggests the
possibility that the pathway can be activated in these brain
areas in adults.
The hallmark of pathway activity and its effector phase is
the nuclear localization of b-catenin. Unfortunately, to the
author’s knowledge, no convincing nuclear immunostain-
ing of b-catenin has been demonstrated in the hippocampus,
along the lateral ventricles, or in the olfactory bulbs [49–
52]. Yet it should be kept in mind that the sensitivity of
immunodetection is limited, and the detection of nuclear
b-catenin is particularly challenging because of its abundant
amounts at the cell membranes. Another concern is the
possible action of b-catenin as a transcription activator in
the adult neurogenic niche, with low expression of LEF1/
TCF genes. Considering the extant in situ hybridization data
[46, 53] and Allen Brain Atlas (http://mouse.brain-map.org;
accessed November 15, 2012), no apparent or reproducible
expression of these genes is found in the SGZ, SVZ, or
RMS, with the exception perhaps of weak Tcf7 expression
along the RMS [46]. Notably, however, canonical Wnt
signaling is not expected to be constantly ‘‘on’’ during
aNPC proliferation and differentiation but rather to be
transiently activated in precisely determined places and at
specific times. Therefore, its activity can be difficult to
observe in vivo under physiological conditions.
To overcome this obstacle, several reporter systems have
been used to visualize the activity of the canonical Wnt
pathway using LacZ staining or fluorescent protein. In
BATGAL mice, reporter activity in the SGZ of the hippo-
campus was observed in proliferating cells, including neu-
roblasts, but not in newly generated neurons [47].
Consistent with these results, intense activity of the reporter
in ins-TOPGAL reporter mice was found in aNPCs in the
SGZ [54]. However, only 10 % of DCX? cells, repre-
senting neuron-committed cells and new neurons, displayed
reporter activity. This result suggests downregulation of
Wnt/b-catenin signaling at the neuroblast stage, whereas the
results in BATGAL mice imply later inhibition. The same
contradiction can be observed in the SVZ when comparing
BATGAL and AXIN2-d2EGFP reporter mice. In both
mice, reporter activity in the SVZ was detected in aNPCs
[55, 56], but it was also detected in some DCX? cells in
BATGAL mice [56]. Despite these discrepancies, the
overall picture of Wnt/b-catenin pathway activity in the
adult neurogenic niche appears to be consistent. The
expression of some Wnt molecules and their receptors can
be found in the niches, and the activity of b-catenin/TCFs
complexes can be indirectly observed, at least in aNPCs.
Role of Wnt/b-Catenin Signaling in Adult
Neurogenesis in the Hippocampus
The first study on the involvement of the canonical Wnt
pathway in adult neurogenesis concluded that b-catenin/
TCF signaling is a principal positive regulator of neuro-
genesis in the adult hippocampus [47]. Signaling appeared
to be activated by agents secreted by hippocampal astro-
cytes, probably Wnt3A, which was shown to be expressed
in close proximity to the SGZ. When the Wnt/b-catenin
pathway was inhibited in aNPCs co-cultured with hippo-
campal astrocytes, by the WNT inhibitor sFRP2/3 or
ectopic expression of dominant-negative (dn) Lef1, the
percentage of neuronal lineage cells (DCX?, TUJ1?, or
MAP2?) decreased. Moreover, the ectopic expression of
Wnt3a in aNPC monocultures enhanced the determination
of neuronal fate and stimulated the proliferation of neuro-
blasts [47]. In situ experiments, in which lentiviruses that
carried dnWnt or Wnt3 were stereotactically injected into
the mouse dentate gyrus of the hippocampus, confirmed the
positive influence of the signaling on neuroblast prolifer-
ation [47]. b-Catenin was also shown to be involved in the
maturation of hippocampal neurons. The conditional loss
of b-catenin in newborn neurons of the SGZ led to den-
dritic malformation, again suggesting its positive role in
Neurochem Res (2013) 38:1144–1155 1147
123
neurogenesis at a later stage [57]. Nonetheless, this latter
study did not determine whether the defects were attrib-
utable to a loss of b-catenin’s transcriptional role or its
function in cell adhesion.
An opposing scenario was proposed, based on the
research on Gfap–Cre-driven APC knockout (KO) mice, in
which b-catenin was stabilized in primary aNPCs, regard-
less of canonical Wnt signaling status [58]. The number of
neuronal-committed cells (DCX? or BrdU?/NEUN?)
dramatically decreased in the SGZ in these mice, sug-
gesting that canonical Wnt signaling is a potent inhibitor,
not activator, of neuronal differentiation. In another study,
consistent with the previous one, elimination of baseline
Wnt activity by the Wnt inhibitor Frizzled8-CRD-Fc or
Axin2 overexpression increased the percentage of neuro-
nal-lineage cells under differentiation conditions in vitro
[59]. Care should be taken, however, when drawing con-
clusions about the negative impact of Wnt/b-catenin or
b-catenin/TCF signaling on adult neurogenesis based on
these studies because the specific involvement of b-catenin
was not tested. Thus, other effectors of the Wnt pathway
may have mediated this anti-neurogenic effect.
Role of Wnt/b-Catenin Signaling in Adult
Neurogenesis in the SVZ and Olfactory Bulbs
Investigations on the role of b-catenin signaling in SVZ
neurogenesis have also generated conflicting results and an
even more complex view of Wnt involvement. Several
studies demonstrated a clear mitogenic effect of b-catenin
signaling in primary and intermediate progenitors (i.e., B
and C cells). The activation of b-catenin by Wnt3a, Wnt5a,
or Wnt7a [60, 61] and the ectopic expression of a stable
b-catenin form, i.e., D90b-catenin, increased the prolifer-
ation of neural progenitors in vitro, whereas blockade of
the canonical Wnt pathway by a Wnt antagonist or ectopic
expression of Axin had an opposite effect [61]. The above
experiments were performed under strong mitogenic
stimulation provided by epidermal and fibroblast growth
factors (FGF2 and EGF), thus should be interpreted with
caution. But nonetheless, their results were confirmed
in vivo. The intracranial lentiviral delivery of Axin
decreased proliferation in adult neurogenic niches, whereas
the ectopic expression of D90b-catenin enhanced prolifer-
ation in the SVZ, at least in B progenitors (GFAP?) [61].
In agreement with these experiments, the delivery of D90b-
catenin into mitotic cells in the SVZ by stereotactic ret-
roviral injection increased the number of C progenitors
(MASH?) [55]. Conversely, the inhibition of Wnt/b-
catenin signaling the retroviral delivery of Dkk1, which
encodes an LRP inhibitor, decreased this number. Thus,
according to the above studies, Wnt/b-catenin signaling
promotes the expansion of the neural progenitor pool.
In sharp contrast to the above analyses are results of
other in vivo studies, which were performed on a trans-
genic mouse line that expressed another stabilized form of
b-catenin, b-cateninEx3, in an inducible manner [56]. The
stabilization of b-catenin was achieved by Tamoxifen-
dependent and tissue specific deletion of b-catenin exon 3.
The mice in which b-cateninEx3 expression was induced in
adulthood in Nestin-positive cells (type B and C progeni-
tors), exhibited an approximately two-fold reduction of
proliferation in the SVZ 1 week after the induction.
Explaining this inconsistency is difficult when considering
the different ages of the mice used in these studies, which
varied from 1 to 2 months. The mode of b-catenin stabil-
ization also unlikely mattered because the D90b-catenin
and b-cateninEx3 forms are not substantially different.
Likewise, vague is the role of b-catenin in the differ-
entiation of neurons in the SVZ and along the RMS. aNPC
cultures exhibited an approximately twofold increase in the
percentage of mature (MAP2?) neurons under differenti-
ation conditions when treated with WNT3a or WNT5a
[60]. This resulted from an increase in the neuronal fate
choice of the progenitors and was not caused by an
expansion of neuroblasts. The same occurrence (i.e., a
twofold increase in the proportion of newly generated
[PSA-NCAM?] neurons) was observed in vivo in the SVZ
upon the induction of b-cateninEx3 [56], which was
accompanied by an increase in Lef1 expression, a well-
known target gene of b-catenin/TCF.
In contrast, the cell-specific deletion of APC, leading to
the accumulation of b-catenin in intermediate progenitors
(MASH?) in the SVZ, dramatically decreased the number
of neuroblasts (DCX?) in vivo, implying an essential
impairment of neurogenesis at the stage of neuroblast
generation [58]. However, in APC KO differentiation cul-
tures, neuronal lineage cells (TUJ1?) displayed abnormal
morphology with no neurites and did not express markers
of newly generated neurons, DCX or PSA-NCAM. This
suggests that APC deletion did not prevent the induction of
neuronal fate but rather disturbed proper differentiation and
maturation. Moreover, whether this effect was b-catenin-
dependent was not determined. APC, in addition to regu-
lating b-catenin levels, can bind to microtubules and
influence axon growth; thus, the described phenotype could
be, at least partially, attributable to this action of APC [62].
Does the Wnt/b-Catenin Pathway Determine the Self-
Renewal or Differentiation of aNPCs?
In summary, most of the studies presented herein indicate a
positive effect of Wnt/b-catenin signaling on aNPC pro-
liferation [55, 60, 61] and determination of neuronal fate
[47, 56, 60]. Additionally, Wnt/b-catenin signaling pro-
moted the proliferation of hippocampal aNPCs [47].
1148 Neurochem Res (2013) 38:1144–1155
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Nevertheless, research that demonstrated the opposite (e.g.,
an inhibitory effect of b-catenin on aNPC proliferation in
the SVZ [56]) cannot be ignored. b-Catenin may activate
different, even opposing, genetic programs, depending on
the particular context (e.g., the availability of specific
partners) [63, 64]. Therefore, b-catenin/TCF signaling can
likely exert both positive and negative effects on the
maintenance of neuronal progenitors and neuronal differ-
entiation, what could explain the discrepancies between
different studies. This possibility will be discussed in the
next chapter.
Although direct proof of the involvement of gene reg-
ulation by b-catenin/TCF complexes in adult neurogenesis
is mostly lacking in the discussed works, a multitude of
indirect evidence makes its role in this process widely
accepted. Nonetheless, one should be cautious when
drawing conclusions. For example, although treatment with
WNT3a or pharmacological inhibition of GSK3a/b
increased the neuronal differentiation of NPCs isolated
from neonatal mouse cortex [48], the activation of
b-catenin/TCF was detected only in a small fraction of
these cells, and most of them expressed neither the neural
progenitor marker Nestin nor marker of neuronal com-
mitted cells TUJ1. Thus, mechanisms other than activation
of b-catenin might be responsible for the promotion of
neuronal differentiation, such as cross-talk of the Wnt/
GSK3 pathway with the Notch pathway [48, 65].
b-Catenin Activators and Partners Might Modify
the Outcome of b-Catenin/TCF Signaling in Neuronal
Differentiation
Canonical Wnt signaling is known to be context-dependent,
[66]. This means that the precise time and manner of Wnt
pathway activation and specific cellular microenvironment
affect the final outcome of the signaling. Efforts to determine
the actual profile of Wnt pathway components, including
activators, inhibitors, and mediators, and the occurrence of
associated factors under specific physiological conditions
might help explain its role at different stages of neurogenesis.
A good example of research that is moving in this
direction is the analysis of WNT7A and TLX (NR2E1)
relationships during the proliferation of aNPCs [61]. Wnt7a
and Tlx are both expressed in proliferating but not differ-
entiating aNPCs in vitro [61]. TLX, a transcription factor,
is a known regulator of aNPC self-renewal [47, 67],
whereas the Wnt7a gene can be activated by TLX [61]. Tlx
silencing or Tlx KO caused a deficiency of aNPC prolif-
eration (in vitro or in vivo in the SVZ), which could be
rescued by WNT7A treatment or expression of the active
form of b-catenin [61]. This suggests that TLX promotes
aNPC proliferation by inducing production of WNT7A,
which then activates b-catenin in an autocrine manner.
A protein that might be involved in modulating the
outcome of canonical Wnt signaling activation is HIPK1
from the HIPK family of seronine/threonine kinases. HIPK
proteins can interact with b-catenin and activate or repress
b-catenin/TCF target genes [56, 68]. Hipk1 is expressed in
embryonic and adult neurogenic niches [56]. Interestingly,
alterations of HIPK1 and b-catenin levels in embryonic
neurogenic niches influenced the balance between cell
proliferation and differentiation, the latter estimated based
on the number of neural progenitors (RC2? cells) and new
neuronal-committed cells (TUJ1?) [56]. This suggests that
HIPK1 can switch the b-catenin-dependent program from
proliferation to differentiation. Because the level of Hipk1
expression strongly increases in primary (B-type) progen-
itors in the SVZ in adults, the hypothesized role of HIPK1
is to modify the outcome of b-catenin signaling in aNPCs
toward the inhibition of stem cell renewal and promotion of
neuronal differentiation (Fig. 3a) [56].
b-Catenin/TCF Target Genes in Neuronal
Differentiation
To understand the precise mechanism of action of canon-
ical Wnt signaling during adult neurogenesis, determining
its actual target genes during both the clonal expansion and
differentiation of neuronal progenitors is necessary. Many
of the known b-catenin/TCF targets encode proteins that
are involved in cell cycle progression [69], for example the
Cyclin D1 gene, making the signaling a potent activator of
cell proliferation. Whether these genes are indeed activated
in proliferating neuronal progenitors by b-catenin is not
known. With regard to neuronal differentiation, cell-type
specific target genes are expected to be activated by
canonical Wnt. To date, three direct targets of b-catenin/
TCF have been described in differentiating aNPCs. One of
these is the Ink4a gene that encodes a general inhibitor of
cell proliferation [70], and the other two, Neurod1 and
Prox1, encode proteins that are transcription factors spe-
cifically involved in neuronal differentiation [71–73].
The Ink4a promoter has been previously shown to have
a LEF1/TCF motif [74] and be inhibited by b-catenin in a
melanoma cell line [75]. In neurons, b-catenin appears to
activate the Ink4a gene in aNPCs in vitro but only in
cooperation with HIPK1, which is mentioned in the pre-
vious chapter [56]. In turn, activation of the Neurod1
promoter by b-catenin in aNPCs depends on the overlap-
ping SOX/TCF binding site [76]. SOX2 is a repressor of
neuronal differentiation [77, 78], and b-catenin is likely
able to reverse the repression by removing SOX2 from the
Neurod1 promoter. Finally, chromatin immunoprecipita-
tion assay performed on aNPC showed association of
b-catenin with the enhancer region of Prox1, which is
specifically expressed in the dentate gyrus in adults [71].
Neurochem Res (2013) 38:1144–1155 1149
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Many more genes can likely be regulated by b-catenin/TCF
during adult neurogenesis. This was indicated by an in
silico study that revealed the substantial and highly sig-
nificant enrichment of putative LEF/TCF target genes in
the genes that encode proteins involved in neuronal dif-
ferentiation [79].
Activation of b-Catenin and Synaptic Plasticity
NMDA-Dependent Nuclear Translocation of b-Catenin
Intensive synaptogenesis occurs during early development
and infancy; nevertheless, new synapses are formed in the
brain throughout life. Depending on neuronal activity,
synapses disappear, are stabilized, are weakened, or are
strengthened [80]. These phenomena, which are referred to
as synaptic plasticity, allow the refinement of neuronal
circuits in the mature brain and provide a basis for learning
and memory formation. Synaptic activity is associated with
signal transduction both locally in the synapse and at the
cell-wide level. An example of local changes is dephos-
phorylation of b-catenin at Tyr654 and its subsequent
translocation from dendritic shafts to dendritic spines,
followed by the binding to Cadherins [81]. Long-lasting
changes in synapses, however, require the activation of
gene expression [82]. Such intracellular responses to neu-
ronal excitation are regulated by signaling cascades that are
initiated mainly by Ca2? influx through the ionotropic




























Fig. 3 Possible roles of b-catenin in neurons in the adult brain. a A
hypothetical model of mitogenic and neurogenic roles of b-catenin/
TCF complexes during adult neurogenesis, modulated by HIPK1 [56,
61]. b Three hypothetical scenarios of NMDA-dependent nuclear
translocation of b-catenin, involving Calpain [85], Lapser1 [86], and
Wnt [84]. c Constant activity of b-catenin/TCF complexes in thalamic
neurons [89]
1150 Neurochem Res (2013) 38:1144–1155
123
aspartate (NMDA) [83]. The classic pathway in this con-
text is the activation of the transcription factor cyclic
adenosine monophosphate response element binding pro-
tein (CREB) mediated by Ca2? and calcium/calmodulin-
dependent kinase IV [82].
Several years ago, b-catenin was hypothesized to be
used to transduce some synaptic activity-dependent signals
into the nucleus (Fig. 3b) [41]. The hypothesis was based
on the observation that tetanic stimulation of dentate gyrus
neurons in hippocampal slices induced the release of
WNT3a and increased the nuclear accumulation of
b-catenin by approximately 20 % [84]. The activation of
b-catenin was NMDA-dependent because it was blocked
by the NMDA receptor antagonist APV. Wnt signaling was
also required for the accumulation of b-catenin, which was
demonstrated by treatment with Frizzled8-CRD-Fc, a
WNT inhibitor. Importantly, activation of the canonical
Wnt pathway during stimulation had a positive impact on
long-term potentiation. Its magnitude decreased when Wnt
signaling was blocked by Frizzled8-Fc or an anti-WNT3a
antibody and increased when it was additionally activated
by recombinant WNT3a or LiCl [84].
Although two other groups of researchers confirmed the
nuclear localization of b-catenin in neurons upon stimulation
of NMDA receptors in rat hippocampal cells in culture, they
proposed different mechanisms of b-catenin accumulation
and concluded that the Wnt pathway was not involved
[85, 86]. In the first study, b-catenin was found to be cleaved
at the N-terminus after stimulation. Only a C-terminus-spe-
cific antibody could detect b-catenin in the nuclei of stimu-
lated hippocampal neurons, implying that exclisively the
truncated pool translocates [85]. The truncation of b-catenin
was effectuated by Calpain, a Ca2?-activated protease.
Application of the Calpain inhibitor MDL28170 abolished
not only cleavage but also translocation in a Wnt-indepen-
dent manner, indicating a new mechanism of b-catenin
regulation in stimulated neurons. The authors proposed that
the cleavage led to the accumulation of b-catenin by pre-
venting its degradation because the truncated isoform could
not be phosphorylated by GSK3a/b and consequently could
not be targeted to the proteasome (Fig. 3b). However, the
other study detected nuclear b-catenin by both C-terminus-
and N-terminus-specific antibodies, conflicting with the
cleavage hypothesis. They proposed that Lapser1, which
belongs to the Fezzin family of postsynaptic density proteins
[87], can interact with b-catenin [88] and is involved in the
redistribution of b-catenin after synaptic stimulation [86]
(Fig. 3b). Lapser1 was found to shuttle to the nucleus upon
treatment with NMDA or glutamate but not a-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) or
K?, similar to b-catenin [86]. The authors claimed that
although Lapser1 silencing did not abolish the nuclear
import of b-catenin, it impaired its later export. Some doubts,
however, are raised by the fact that high concentrations of b-
catenin in cell bodies and nuclei were visible even in non-
stimulated neurons, which was contradictory to what was
shown by others in primary cultures of hippocampal neurons
[85, 89].
The only in vivo evidence for the neuronal excitation-
dependent activation of b-catenin was derived from a study
performed in TOPGAL mice that were subjected to a
novelty exploration test [85]. The number of b-galactosi-
dase-positive neurons in the CA3 field of the hippocampus
increased, indirectly indicating the activation of b-catenin/
TCF-dependent genes. Treatment with MDL28170 abol-
ished this effect, confirming the involvement of Calpain.
Further studies are necessary to confirm the nuclear
translocation of b-catenin and determine its actual impor-
tance in synaptic plasticity and learning.
Possible Target Genes of b-Catenin/TCF in Excited
Neurons
An expected effect of the nuclear translocation of
b-catenin in excited neurons is the activation of plasticity-
related genes. A set of known b-catenin/TCF targets
(Cd44, Ccnd1, Cldn1, Dll1, Fas, Wisp2, Fosl1, and Myc)
were found to be upregulated after tetanic stimulation or
glutamate treatment [84–86]. Interestingly, an in silico
genome-wide analysis revealed significant enrichment of
putative LEF1/TCF targets in neuronal genes that encode
voltage-gated channels and synaptic proteins, including
structural proteins, neurotransmitter receptors, and proteins
associated with synaptic vesicles [79]. These genes are
good candidates for b-catenin/TCF targets in glutamate-
stimulated neurons when considering their possible impact
on synaptic plasticity, provided that they are actually
activated by the treatment, which is currently unknown.
Role of b-Catenin in the Adult Thalamus
Constant Activity of b-Catenin in Thalamic Neurons
b-Catenin is an intracellular signaling effector that sup-
posedly undergoes nuclear translocation upon activation.
Surprisingly, however, the constant nuclear localization of
b-catenin was observed in neurons in subcortical structures
that are involved in the integration of sensory information,
including the thalamus, epithalamus, pretectum, periaqu-
eductal grey, and superior colliculus [50, 52]. Interestingly,
the accumulation of b-catenin was accompanied by high
levels of TCF7L2 and LEF1 proteins [52]. LEF1 was also
detected in the entorhinal cortex, and TCF7L2 was detec-
ted in the inferior colliculus, but b-catenin was not detected
in the cellular nuclei in these regions [52].
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What causes b-catenin to accumulate in the nuclei of
these neurons? This phenomenon is apparently cell-
autonomous because growing thalamic neurons in disso-
ciated primary cultures without glial cells did not abolish
the nuclear localization of b-catenin [89]. b-Catenin
accumulation appears to be independent of Wnt pathway
activation. The inhibition of Wnt signal transmission by
treatment with DKK1, an inhibitor of LRP5/6 co-receptors,
or ectopic expression of a dominant-negative form of
Disheveled, a mediator of Wnt signaling that acts down-
stream of the Frizzled receptor, did not affect the nuclear
accumulation of b-catenin [89]. The accumulation instead
seemed to result from low levels of proteins that constitute
the b-catenin destruction complex: GSK3a/b, AXIN1, and
APC [89] (Fig. 3c). Indeed, degradation of the cytoplasmic
fraction of b-catenin is less effective in thalamic neurons
than in cortical or hippocampal neurons.
Genetic Program Activated by b-Catenin
in the Thalamus
Gene profiling in the forebrain revealed that voltage-
gated ion channel and neurotransmitter receptor genes,
which have at least two LEF1/TCF motifs in their
putative regulatory sequences, are preferentially expres-
sed in the thalamus [79]. A loss-of-function experiment
in primary thalamic cultures by the ectopic expression of
Axin2, and immunoprecipitation of forebrain chromatin
with an anti-b-catenin antibody provided evidence of the
direct regulation of at least Cacna1g, Kcna6 (voltage-
gated channel genes), Gabra2 (GABA receptor gene),
and Calb2 (which encodes a calcium buffer, Calretinin)
in the thalamus [79]. The Cacna1g promoter in particular
was shown to be activated by LEF1 and b-catenin in a
luciferase assay and to bind LEF1 in a footprinting test
[49], confirming that it is a genuine target of b-catenin
and LEF1/TCF factors. Cacna1g encodes the Cav3.1
subunit of so-called T-type channels that are critical for
the function of thalamocortical relay neurons. T-type
channels underlie the principal electrical property of
these neurons, i.e., the intrinsic possibility to fire in two
modes [90]. This feature enables the modification of the
format of information that is sent to the cortex and is
believed to regulate sleep/wakefulness and awareness
[91]. Importantly, an additional activation of b-catenin
enhanced T-type current in thalamic neurons in culture
[49]. The constant nuclear localization of b-catenin and
LEF1/TCF transcription factors in thalamic neurons in
adults, together with the regulation of crucial thalamic
genes by these factors, suggests that b-catenin/TCF
might maintain molecular identity of thalamic neurons.
Future Directions
Knowledge about the role of canonical Wnt signaling
effectors in the adult brain is still relatively superficial and
inconclusive. Many studies have focused on the activation
or inhibition of the canonical Wnt pathway while assuming
concomitant changes in nuclear b-catenin activity and the
availability of LEF1/TCF factors. In turn, when directly
targeting b-catenin, research faces a major difficulty when
attempting to delineate its adhesive and nuclear functions
in a given cellular or physiological process. Wnt research
suffers from insufficient tools to inhibit the nuclear
canonical Wnt pathway and a lack of sophisticated animal
models. The hope is that such tools and models will be
soon be developed and implemented in fundamental and
application neuroscience.
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